Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Delta Air Lines, Inc. (DAL) - free report >>
Hologic, Inc. (HOLX) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Delta Air Lines, Inc. (DAL) - free report >>
Hologic, Inc. (HOLX) - free report >>
Image: Bigstock
New Strong Buy Stocks for July 17th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Delta Air Lines, Inc. (DAL - Free Report) : This company that provides scheduled air transportation for passengers and cargo has seen the Zacks Consensus Estimate for its current year earnings increasing 6.3% over the last 60 days.
Delta Air Lines, Inc. Price and Consensus
Delta Air Lines, Inc. price-consensus-chart | Delta Air Lines, Inc. Quote
Sunoco LP (SUN - Free Report) : This company that engages in the distribution and retailing of motor fuels has seen the Zacks Consensus Estimate for its current year earnings increasing 16.7% over the last 60 days.
Sunoco LP Price and Consensus
Sunoco LP price-consensus-chart | Sunoco LP Quote
Alexion Pharmaceuticals, Inc. : This biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 0.1% over the last 60 days.
Alexion Pharmaceuticals, Inc. Price and Consensus
Alexion Pharmaceuticals, Inc. price-consensus-chart | Alexion Pharmaceuticals, Inc. Quote
Exelixis, Inc. (EXEL - Free Report) : This oncology-focused biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 1.1% over the last 60 days.
Exelixis, Inc. Price and Consensus
Exelixis, Inc. price-consensus-chart | Exelixis, Inc. Quote
Hologic, Inc. (HOLX - Free Report) : This medical technology company has seen the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 90 days.
Hologic, Inc. Price and Consensus
Hologic, Inc. price-consensus-chart | Hologic, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2018, while the S&P 500 gained +15.8%, five of our screens returned +38.0%, +61.3%, +61.6%, +68.1%, and +98.3%.
This outperformance has not just been a recent phenomenon. From 2000 – 2018, while the S&P averaged +4.8% per year, our top strategies averaged up to +56.2% per year.
See their latest picks free >>